Upload
shanaz-alvikha
View
226
Download
0
Embed Size (px)
Citation preview
8/12/2019 Congenital Rubella
1/15
CONGENITAL RUBELLA
SYNDROMEInfectious and Tropical Pediatric Division
Department of Child Health
Medical Faculty, University of Sumatera Utara
8/12/2019 Congenital Rubella
2/15
What is Rubella
Rubella (German measles) is a diseasecaused by the rubella virus. Rubella is
usually a mild illness. Most people whohave had rubella or the vaccine areprotected against the virus for the rest oftheir lives. Because of routine vaccination
against rubella since 1970 , rubella is nowrarely reported.
8/12/2019 Congenital Rubella
3/15
History - Rubella
The Teratogenic property of theinfection was documented by an
Australian opthalmologist Greeg in1941
8/12/2019 Congenital Rubella
4/15
Rubella
( German Measles )
Rubella is alsocalled as 3 dayMeasles or German
Measles. Family Togaviridae
Genus - Rubivirus
In general belongto Togavirus group
8/12/2019 Congenital Rubella
5/15
Rubella Virus
Rubella virus are
ss RNA virus
Diameter 5070 nm
Enveloped Spherical
Virus carryhemagglutinin
Virus multiply in thecytoplasam of infectedcell.
8/12/2019 Congenital Rubella
6/15
Epidemiology
Rubella is world wide in distribution
Occurs round the year,
Epidemics occur every 2025 years
Infection is transmitted by respiratoryroute
The use of Rubella vaccine has noweliminated both epidemic and endemicRubella in USA and several developedcountries
8/12/2019 Congenital Rubella
7/15
Treatment and Prevention
Rubella is a mild self limited illness.
No specific treatment or Antiviraltreatment is indicated.
However Laboratory proved andclinically missed Rubella in the Ist 3-4 months of pregnancy is associatedwith fetal infections.
8/12/2019 Congenital Rubella
8/15
Congenital Rubella Syndrome
Maternal viremia with Rubella infectionduring pregnancy may result in infectionof placenta and fetus.
The growth rate of fetal cells are reduced. Results in fewer number of cells after the
birth.
Lead to deranged and hypo plastic organ
development. Results in structural damage and
abnormalities
8/12/2019 Congenital Rubella
9/15
Rubella infection t varioustrimesters
Isttrimester infections lead to abnormalities in85 % of cases. and greater damage to organs
2ndtrimester infections lead to defects in 16 %
> 20 weeks of pregnancy fetal defects areuncommon
However Rubella infection can also lead to fetaldeaths, and spontaneous abortion.
The intrauterine infections lead to viral excretionin various secretion in newborn upto 12-18months.
8/12/2019 Congenital Rubella
10/15
Clinical Findings
( Congenital Rubella Syndrome )
May be transient effects in infants.
Permanent manifestations may beapparent at birth, becomerecognized during the first year.
Developmental abnormalities appearduring childhood and adolescents.
8/12/2019 Congenital Rubella
11/15
Classical Triad of Rubella
Classical Triad ataract ardiac abnormalities Deafness
Other manifestationsGrowth retardation
RashHepatosplenomegaly
JaundiceMeingoencephalitisCNS defects lead tomoderate to profound
mental retardation
8/12/2019 Congenital Rubella
12/15
Other Neurological manifestions
Problems in balance
Motor skills inpreschool childrenaltered.
A rare complication ofPan encephalitis canoccur in seconddecade with
Congenital rubellasyndrome mayprogress to death.
8/12/2019 Congenital Rubella
13/15
Diagnosis of
Congenital Rubella Syndrome
Demonstration ofRubella antibodies
of IgM in a newborn is diagnosticvalue. As IgMgroup donot cross
the placenta andthey are produce inthe infected fetus,
8/12/2019 Congenital Rubella
14/15
Treatment, Prevention, Control
No specific treatmentis available
CRS can be prevented by effective
immunization of the young children
and teenage girls, remain the best
option to prevent Congenital Rubella
Syndrome.
The component of Rubella in MMR
vaccine protects the vaccinated
8/12/2019 Congenital Rubella
15/15
MMR Vaccine
The MMR vaccineis a mixture of three liveattenuated viruses, administered via injection forimmunizationagainst measles, mumpsandrubella. It is generally administered to children
around the age of one year, with a second dosebefore starting school (i.e. age 4/5). The seconddose is not a booster; it is a dose to produceimmunity in the small number of persons (2-5%)who fail to develop measles immunity after the
first dose In the United States, the vaccine waslicensed in 1963 and the second dose wasintroduced in the mid 1990s. It is widely used inall National, Universal Immunization programmes
http://en.wikipedia.org/wiki/Attenuated_virushttp://en.wikipedia.org/wiki/Immunizationhttp://en.wikipedia.org/wiki/Measleshttp://en.wikipedia.org/wiki/Mumpshttp://en.wikipedia.org/wiki/Rubellahttp://en.wikipedia.org/wiki/Booster_dosehttp://en.wikipedia.org/wiki/Booster_dosehttp://en.wikipedia.org/wiki/Rubellahttp://en.wikipedia.org/wiki/Mumpshttp://en.wikipedia.org/wiki/Measleshttp://en.wikipedia.org/wiki/Immunizationhttp://en.wikipedia.org/wiki/Attenuated_virus